Plasma levels of soluble E-cadherin and the keratinocytes growth factor in intrauterine growth restriction


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. To investigate plasma levels of soluble E-cadherin (sE-cad) and the keratinocytes growth factor (KGF) in women with fetal growth restriction (FGR). Materials and methods. The study included 25pregnant women with fetal growth restriction and 19 women with a healthy pregnancy. Plasma levels of sE-cad and KGF were determined by ELISA. Results. In women with FGR, the plasma level of sE-cad was decreased (p=0.006), while the KGF level was increased (p=0.037). ROC analysis assessing the diagnostic accuracy of sE-cad and KGF showed the AUC of 0.74 and 0.69, respectively. A low plasma level of sE-cad in women with FGR reflects impaired mobility and proliferative activity of trophoblast cells. In growth-restricted pregnancy, higher levels of KGF, as a proliferation factor, may be associated with the activation of compensatory mechanisms aimed to improve trophoblast cell proliferation. Conclusion. Plasma levels of sE-cad and KGF in pregnant women reflect the underlying pathological process interfering with the healthy growth of the placenta and may, therefore, be used as markers offetal growth restriction.

Full Text

Restricted Access

About the authors

Aleksey M. Krasnyi

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: alexred@list.ru
Ph.D. (bio.sci.), Head of the Cytology Laboratory

Anuta A. Khachaturyan

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: x.anyt37@mail.ru
Ph.D. Student

Valentina V. Vtorushina

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: v_vtorushina@oparina4.ru
Ph.D., Laboratory Physician at the Laboratory of Clinical Immunology

Lubov V. Krechetova

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia

Email: l_krechetova@oparina4.ru
PhD, MD(Medicine), Head of the laboratory of clinical immunology

Natalia E. Kan

V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of Minzdrav of Russia; European Medical Center

Email: kan-med@mail.ru
Dr.Med.Sci., Head Physician of the Perinatal Center of European Medical Center, Professor at the Department of Obstetrics and Gynecology

Victor L. Tyutyunnik

European Medical Center

Email: tioutiounnik@mail.ru
Dr.Med.Sci., Deputy Head Physician

References

  1. Стрижаков А.Н., Игнатко И.В., Тимохина Е.В., Белоцерковцева Л.Д. Синдром задержки роста плода. Патогенез. Диагностика. Лечение. Акушерская тактика. М.: ГЭОТАР-Медиа; 2012. 120 с. [Strizhakov A.N., Ignatko I.V., Timohina E.V., Belotserkovtseva L.D. Fetal growth retardation. Pathogenesis. Diagnostics. Treatment. Obstetric tactics. Moscow: GEOTAR-Media; 2012. 120 р. (in Russian)].
  2. Unterscheider J., Daly S., Geary M.P., Kennelly M.M., McAuliffe F.M., ODonoghue K. et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am. J. Obstet. Gynecol. 2013; 208(4): 290. e1-6. https://dx.doi.org/10.1016/j.ajog.2013.02.007.
  3. Gardosi J., Madurasinghe V., Williams M., Malik A., Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ. 2013; 346: f108. https:// dx.doi.org/10.1136/bmj.f108.
  4. Sharma D., Shastri S., Sharma P. Intrauterine growth restriction: antenatal and postnatal aspects. Clin. Med. Insights Pediatr. 2016; 10: 67-83. https://dx.doi. org/10.4137/CMPed.S40070. eCollection 2016.
  5. Andreadis S.T., Hamoen K.E., Yarmush M.L., Morgan J.R. Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system. FASEB J. 2001; 15(6): 898-906. https://dx.doi.org/10.1096/ fj.00-0324com.
  6. Najy A.J., Day K.C, Day M.L. The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. J. Biol. Chem. 2008; 283(26): 18393-401. https://dx.doi.org/10.1074/jbc.M801329200.
  7. Красный А.М., Хачатурян А.А., Кан Н.Е., Хачатрян З.В., Тютюнник В.Л., Волгина Н.Е., Ганичкина М.Б., Мантрова Д.А., Садекова А.А. Роль Е-кадгерина в формировании задержки роста плода. Акушерство и гинекология. 2018; 6: 38-43. [Krasnyi A.M., Khachaturyan A.A., Kan N.E., Khachatryan Z.V., Tyutyunnik V.L., Volgina N.E., Ganichkina M.B., Mantrova D.A., Sadekova A.A. The role E-kadherin in the formation of intrauterine growth restriction. Akusherstvo i ginekologiya / Obstetrics and Gynecology. 2018; (6): 38-43. (in Russian)]. https://dx.doi.org/10.18565/ aig.2018.6.38-43.
  8. Szukiewicz D., Szewczyk G., Watroba M., Kurowska E., Maslinski S. Isolated placental vessel response to vascular endothelial growth factor and placenta growth factor in normal and growth-restricted pregnancy. Gynecol. Obstet. Invest. 2005; 50(2): 102-7. https://dx.doi.org/10.1159/000082622.
  9. Brouxhon S.M., Kyrkanides S., Raja V., Silberfeld A., Teng X., Trochesset D. et al. Ectodomain-specific E-cadherin antibody suppresses skin SCC growth and reduces tumor grade: a multitargeted therapy modulating RTKs and the PTEN-p53-MDM2 axis. Mol. Cancer Ther. 2014; 13(7): 1791-802. https://dx.doi. org/10.1158/1535-7163.MCT-13-0971.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Bionika Media